Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its results for the first half of the ...

Following a reworked joint venture agreement for Amplitude Energy's Otway project, analysts highlight greater development and funding certainty ...

Intech Investment Management LLC increased its stake in Amplitude, Inc. (NASDAQ:AMPL – Free Report) by 96.4% during the 4th ...

These shares are starting the week on a high. But why? The post Why Amplitude Energy, Catapult, Gorilla Gold, and Mineral ...

Amplitude, a leading digital analytics platform, is unveiling a new iteration of Session Replay-the solution for visualizing enterprises' digital analytics-that more deeply integrates into every ...

I reiterate my buy rating for Amplitude stock, expecting mid-teens revenue growth and a 20% upside to the share price. AMPL's enterprise sales strategy is driving significant ARR growth ...

Piper Sandler analyst Brent Bracelin maintained a Buy rating on Amplitude (AMPL – Research Report) today and set a price target of $17.00. The ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to be a strong Indian global player in the med devices space, says Dr Sharvil ...

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its results for the first half of the ...

In a report released today, Scott Berg from Needham reiterated a Buy rating on Amplitude (AMPL – Research Report), with a price target of ...